Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems

被引:17
作者
Lin, Yu Kuei [1 ]
Groat, Danielle [2 ]
Chan, Owen [1 ]
Hung, Man [3 ]
Sharma, Anu [1 ]
Varner, Michael W. [4 ]
Gouripeddi, Ramkiran [2 ]
Facelli, Julio C. [2 ]
Fisher, Simon J. [1 ]
机构
[1] Univ Utah, Sch Med, Dept Internal Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA
[2] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Study Design & Biostat Ctr, Ctr Clin & Translat Sci, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA
关键词
Hypoglycemia; Impaired awareness of hypoglycemia; Continuous glucose monitoring; Type; 1; diabetes; IMPAIRED AWARENESS; GLYCEMIC THRESHOLDS; INSULIN INJECTIONS; AUTONOMIC FAILURE; ADULTS; COUNTERREGULATION; MULTICENTER; CONSENSUS; SYMPTOMS;
D O I
10.1089/dia.2020.0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods:For this cross-sectional observational study, 99 T1D patients using real-time CGMs for >= 86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results:IAH was associated with greater percentages of CGM values <70 and <54 mg/dL (P = 0.012,P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL (P = 0.013,P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at >= 1 time point (P = 0.048,P = 0.003) or lasting >= 20 min (P = 0.016,P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL (P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL (P = 0.009,P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL (P < 0.001,P = 0.006), respectively. Conclusions:T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 40 条
  • [21] An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes
    Geddes, Jacqueline
    Wright, Rohana J.
    Zammitt, Nicola N.
    Deary, Ian J.
    Frier, Brian M.
    [J]. DIABETES CARE, 2007, 30 (07) : 1868 - 1870
  • [22] Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
    Heinemann, Lutz
    Freckmann, Guido
    Ehrmann, Dominic
    Faber-Heinemann, Gabriele
    Guerra, Stefania
    Waldenmaier, Delia
    Hermanns, Norbert
    [J]. LANCET, 2018, 391 (10128) : 1367 - 1377
  • [23] Assessing impaired hypoglycemia awareness in type 1 diabetes - Agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia
    Janssen, MMJ
    Snoek, FJ
    Heine, RJ
    [J]. DIABETES CARE, 2000, 23 (04) : 529 - 532
  • [25] Lin YK, 2020, ZENODO
  • [26] Alarm Settings of Continuous Glucose Monitoring Systems and Associations to Glucose Outcomes in Type 1 Diabetes
    Lin, Yu Kuei
    Groat, Danielle
    Chan, Owen
    Hung, Man
    Sharma, Anu
    Varner, Michael W.
    Gouripeddi, Ramkiran
    Facelli, Julio C.
    Fisher, Simon J.
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (01)
  • [27] IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES
    Lin, Yu Kuei
    Hung, Man
    Sharma, Anu
    Chan, Owen
    Varner, Michael W.
    Staskus, Gitana
    Fisher, Simon J.
    [J]. ENDOCRINE PRACTICE, 2019, 25 (06) : 517 - 525
  • [28] Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial
    Lind, Marcus
    Polonsky, William
    Hirsch, Irl B.
    Heise, Tim
    Bolinder, Jan
    Dahlqvist, Sofia
    Schwarz, Erik
    Olafsdottir, Arndis Finna
    Frid, Anders
    Wedel, Hans
    Ahlen, Elsa
    Nystrom, Thomas
    Hellman, Jarl
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 379 - 387
  • [29] Recovery of Hypoglycemia Awareness in Long-standing Type 1 Diabetes: A Multicenter 2 x 2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-monitoring (HypoCOMPaSS)
    Little, Stuart A.
    Leelarathna, Lalantha
    Walkinshaw, Emma
    Tan, Horng Kai
    Chapple, Olivia
    Lubina-Solomon, Alexandra
    Chadwick, Thomas J.
    Barendse, Shalleen
    Stocken, Deborah D.
    Brennand, Catherine
    Marshall, Sally M.
    Wood, Ruth
    Speight, Jane
    Kerr, David
    Flanagan, Daniel
    Heller, Simon R.
    Evans, Mark L.
    Shaw, James A. M.
    [J]. DIABETES CARE, 2014, 37 (08) : 2114 - 2122
  • [30] HIERARCHY OF GLYCEMIC THRESHOLDS FOR COUNTERREGULATORY HORMONE-SECRETION, SYMPTOMS, AND CEREBRAL-DYSFUNCTION
    MITRAKOU, A
    RYAN, C
    VENEMAN, T
    MOKAN, M
    JENSSEN, T
    KISS, I
    DURRANT, J
    CRYER, P
    GERICH, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01): : E67 - E74